Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our commitment to a healthier, brighter future for all. 🧬
Privacy Notice: https://idtb.io/privacy

@idtdna.bsky.social
Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our commitment to a healthier, brighter future for all. 🧬
Privacy Notice: https://idtb.io/privacy
🔥Tomorrow is the last day to take advantage of free IDT products for your #iGEM project!🔥
We offer up to 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products to registered teams. Hurry and grab your supplies before the deadline closes: https://idtb.io/79d14nf3
Meet us in Montréal for #ASHG2026! Stop by booth #1216 to connect with IDT’s trusted experts and learn how our flexible, end-to-end genomics solutions support #cancerresearch, translational studies, and #biomarkerdiscovery from sample to insight. Learn more here: https://ashgmeeting.ashg.org/
Meet us at Festival of Biologics! Stop by booth #360 to discover how we're helping researchers accelerate breakthroughs with synthetic biology, NGS, and advanced genomics solutions: https://lifesciences.danaher.com/us/en/events/festival-biologics.html
As AI transforms what's possible in biology, staying ahead of emerging risks is critical. See how IDT and industry collaborators are strengthening DNA screening to help protect the bioeconomy while enabling scientific innovation. Read more from IDT's Adam Clore and others: https://ow.ly/fKLt50ZUzq7
Avoid dead-end workflows when your fragment request hits a limit. With IDT and Ansa, there’s a better path forward. ⏩ Our “No Loose Ends” workflow helps guide complex designs beyond fragment fit—toward fully assembled clonal genes, without losing momentum. 🧬
Learn more here: http://idtb.io/07t7jr
#CRISPR/Cas9 transformed #genomeediting, but it's no longer the only option. Explore current approaches and key considerations to choosing the right tool with IDT's Mollie Schubert and Aldevron's Loren Schoch in SEQanswers: https://ow.ly/Flwb50ZFHPe
Big ideas, challenging questions, and meaningful scientific exchange.đź’Ą
Our Advanced Genomics Symposium brought together leading voices in genomics to explore the next frontiers of #CRISPR, #AI, and #DNAsynthesis. Thanks to all who joined us in London!🧬
400 institutions served. Up to 50kb. 97% fulfillment. 42x increase in complexity. IDT+Ansa is a partnership that pushes beyond the traditional 7kb synthesis ceiling, and resets standards. Get greater design freedom here: https://idtb.io/07t7jr
If you registered with IDT for the #iGEM Competition, you have until October 12 to order with us! Be sure to snag your 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products, and take advantage of our free resources: https://idtb.io/79d14nf3
Struggling with difficult-to-maintain #DNAconstructs? 🧬
pStable™ vectors offer a stability-focused approach that helps support propagation of large, repetitive, toxic, and complex sequences while allowing researchers to boost plasmid yield when needed. Read more in our blog: https://idtb.io/v4lc2k17
📣LAST CALL iGEM PARTICIPANTS! Tomorrow is the final day to register with IDT! Take advantage of 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products for your project. Learn more: https://idtb.io/n67bfxr4
It's the last day of #GEAR26! Don't miss your chance to visit the IDT table to discover our CRISPR portfolio, including our new Cas9 mRNA solution and off-target analysis services. See you soon!
We’re excited to announce that we’re partnering with Aldevron to launch a new S.p. Cas9 mRNA solution—offering researchers and therapeutic developers a game-changing approach to gene editing.🙌 Read more here: https://idtb.io/trqtytv7
We’ve made it to Stockholm for #ECP2026! Don’t forget to stop by booth #323 to discover how our Archer™ portfolio supports blood cancer applications like liquid biopsy and hematological malignancy research. See you soon! 👋
The next generation of #MRD and #MCED programs demand unprecedented #DNAcomplexity. Learn how we're helping researchers overcome synthesis limitations with expanded capabilities designed to support sophisticated assay designs and accelerate innovation in #cancerresearch: https://ow.ly/CZKR50ZIrwF
#GEAR26 is almost here! Remember to visit the IDT table to explore our #CRISPR portfolio, including our new #Cas9 mRNA solution and #off-targetanalysis services. Also, check out posters from IDT scientists to see our CRISPR products in action—details below. Learn more here: https://ow.ly/8SXS50ZIiCt
ICYMI: We’re expanding our collaboration with Ansa Biotechnologies to provide broader global access to long and complex #syntheticDNA through a streamlined ordering experience. Over 400 institutions across 33 countries have benefitted from our partnership so far! Learn more: idtb.io/07t7jr
We're excited to connect at #ECP2026! Visit our trusted experts at booth #323 to explore our portfolio of blood cancer research solutions and discover how Archer™ technologies support liquid biopsy and hematological malignancy research.
Learn more: https://www.espcongress.org/
Excited to attend GEAR for the first time! Visit the IDT table to explore our CRISPR portfolio, including our new Cas9 mRNA solution and off-target analysis services. Also, check out posters from IDT scientists to see our CRISPR products in action. Learn more here: https://ow.ly/nX1R50ZIioR
🥳 We’re celebrating our anniversary! Nearly four decades ago, Dr. Joseph Walder founded IDT with a vision to make genomics more accessible and advance scientific discovery. 🧬
Thank you to everyone who has been part of the journey. Learn more: https://ow.ly/Qfsp50ZHEnW